Bimodal population or pathologist artifact? [1]

Journal of Clinical Oncology

Volumn 25, Issue 17, 2007, Pages 2487-2488

  Rimm, David L ^a   Giltnane, Jennifer M ^a   Moeder, Christopher ^a   Harigopal, Malini ^a   Chung, Gina G ^a   Camp, Robert L ^a   Burtness, Barbara ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ARTIFACT; BREAST CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TISSUE MICROARRAY;

ARTIFACTS; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 34347271953     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.7537     Document Type: Letter

References (10)

1. Schnitt SJ: Estrogen receptor testing of breast cancer in current clinical practice: What's the question? J Clin Oncol 24:1797-1799, 2006
2. Collins LC, Botero ML, Schnitt SJ: Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: An analysis of 825 cases. Am J Clin Pathol 123:16-20, 2005
3. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, et al: Immunohistochemistry of estrogen and progesterone receptors reconsidered: Experience with 5,993 breast cancers. Am J Clin Pathol 123:21-27, 2005
4. Umemura S, Itoh J, Itoh H, et al: Immunohistochemical evaluation of hormone receptors in breast cancer: Which scoring system is suitable for highly sensitive procedures? Appl Immunohistochem Mol Morphol 12:8-13, 2004
5. McCabe A, Dolled-Filhart M, Camp RL, et al: Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Natl Cancer Inst 97:1808-1815, 2005
6. Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8:1323-1327, 2002
7. McCarty KS Jr, Szabo E, Flowers JL, et al: Use of a monoclonal antiestrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 46:4244s-4248s, 1986
8. Camp RL, Dolled-Filhart M, King BL, et al: Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res 63:1445-1448, 2003
9. deFazio A, Chiew YE, Sini RL, et al: Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. Int J Cancer 87:487498, 2000
10. Dolled-Filhart M, McCabe A, Giltnane J, et al: Quantitative in situ analysis of {beta}-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 66:5487-5494, 2006